Research Analysts Set Expectations for AMPX Q2 Earnings

Amprius Technologies, Inc. (NYSE:AMPX) – Northland Securities issued their Q2 2027 earnings estimates for Amprius Technologies in a report issued on Thursday, August 6th. Northland Securities analyst T. Jackson forecasts that the company will post earnings of $0.01 per share for the quarter. The consensus estimate for Amprius Technologies’ current full-year earnings is ($0.08) per share. Northland Securities also issued estimates for Amprius Technologies’ Q3 2027 earnings at $0.03 EPS, Q4 2027 earnings at $0.04 EPS and FY2027 earnings at $0.08 EPS.

Amprius Technologies (NYSE:AMPX) last posted its earnings results on Wednesday, May 6th. The company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.02). The company had revenue of $28.54 million for the quarter, compared to analysts’ expectations of $25.72 million. Amprius Technologies had a negative net margin of 35.16% and a negative return on equity of 13.23%.

Other research analysts have also issued research reports about the company. Weiss Ratings restated a “sell (e+)” rating on shares of Amprius Technologies in a research report on Friday, July 17th. Wall Street Zen downgraded Amprius Technologies from a “hold” rating to a “sell” rating in a research report on Saturday, May 9th. Clear Str began coverage on Amprius Technologies in a research note on Tuesday, June 2nd. They set a “strong-buy” rating and a $33.00 price target for the company. JonesTrading began coverage on Amprius Technologies in a report on Friday, July 10th. They set a “buy” rating and a $30.00 price target for the company. Finally, Roth Capital restated a “buy” rating on shares of Amprius Technologies in a report on Friday, May 8th. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $22.50.

Amprius Technologies Stock Performance

Shares of NYSE AMPX opened at $11.20 on Friday. The company has a market cap of $1.59 billion, a P/E ratio of -38.61 and a beta of 2.33. Amprius Technologies has a 52-week low of $6.36 and a 52-week high of $24.23. The firm’s fifty day moving average is $13.65 and its two-hundred day moving average is $14.93.

Institutional Investors Weigh In On Amprius Technologies

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in AMPX. Oppenheimer & Co. Inc. grew its stake in shares of Amprius Technologies by 47.7% during the fourth quarter. Oppenheimer & Co. Inc. now owns 442,090 shares of the company’s stock valued at $3,488,000 after buying an additional 142,751 shares during the last quarter. Stephens Investment Management Group LLC boosted its holdings in Amprius Technologies by 33.1% during the 4th quarter. Stephens Investment Management Group LLC now owns 1,441,698 shares of the company’s stock valued at $11,375,000 after acquiring an additional 358,791 shares during the period. Hussman Strategic Advisors Inc. purchased a new position in Amprius Technologies during the 4th quarter valued at $1,657,000. Vanguard Group Inc. grew its position in Amprius Technologies by 9.5% in the 4th quarter. Vanguard Group Inc. now owns 7,128,657 shares of the company’s stock valued at $56,245,000 after acquiring an additional 616,037 shares during the last quarter. Finally, UBS Group AG grew its position in Amprius Technologies by 35.5% in the 4th quarter. UBS Group AG now owns 2,098,946 shares of the company’s stock valued at $16,561,000 after acquiring an additional 549,892 shares during the last quarter. 5.04% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Amprius Technologies

In other news, Director Donald R. Dixon sold 85,000 shares of the business’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $17.17, for a total value of $1,459,450.00. Following the sale, the director directly owned 359,380 shares in the company, valued at $6,170,554.60. The trade was a 19.13% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CTO Constantin Ionel Stefan sold 28,812 shares of the company’s stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $14.79, for a total transaction of $426,129.48. Following the sale, the chief technology officer owned 804,518 shares in the company, valued at $11,898,821.22. This represents a 3.46% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders sold 310,144 shares of company stock valued at $5,049,997. Corporate insiders own 5.10% of the company’s stock.

Key Stories Impacting Amprius Technologies

Here are the key news stories impacting Amprius Technologies this week:

• Positive Sentiment: Record Q2 revenue reached approximately $34 million, representing 125% year-over-year growth and exceeding expectations. Management also raised its outlook, forecasting at least $140 million in 2026 revenue and a gross margin of at least 28%. Amprius forecasts 2026 revenue and gross margin
• Positive Sentiment: Demand for Amprius’ SiCore batteries is expanding, particularly in defense drones. The company is also increasing NDAA-compliant manufacturing capacity, improving its ability to pursue U.S. defense-related contracts. Q2 earnings call highlights
• Positive Sentiment: Coverage has improved after Zacks Research upgraded AMPX from “strong sell” to “hold.” Reports also cited bullish analyst targets, increased institutional buying and elevated short interest, which could amplify a rebound if operating results continue to improve. Zacks Research
• Neutral Sentiment: The earnings release produced a revenue beat and prompted a sharp initial rally, but the stock’s subsequent volatility suggests investors may be taking profits or demanding more evidence that the upgraded guidance is achievable. Amprius trading after earnings beat
• Negative Sentiment: Amprius remains unprofitable, with a quarterly loss and negative margins. Continued cash needs, production scale-up requirements and dependence on converting battery demand into contracts could limit the stock’s upside despite the strong growth outlook. Amprius Q2 earnings report

About Amprius Technologies

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.